News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PerkinElmer, Inc. (PKI) And Vivascience/Sartorius To Develop Innovative Proteomics-Based Biomarker Platform



10/19/2005 5:11:26 PM

PerkinElmer Inc. (NYSE: PKI), a leading provider of drug discovery, life science research, and analytical solutions and Vivascience AG, a leading supplier of products and technology solutions for protein purification and analysis and member of the Sartorius Group, today announced that they have entered into a collaborative agreement in biomarker screening and discovery.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES